MPST and metabolic dysfunction-associated steatotic liver disease: Of the 15 identifed proteins, MPST was reported to be a potential therapeutic target for NAFLD, and that the fatty acids promote fatty liver disease via the dysregulation of the MPST/hydrogen sulfide pathway (Ref.